Related Experiment Video

Updated: Jun 20, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Systolic heart failure: a prothrombotic state

Olav R de Peuter1, Wouter E M Kok, Christian Torp-Pedersen

  • 1Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, 1100 DD Amsterdam, The Netherlands. O.R.dePeuter@amc.uva.nl

Seminars in Thrombosis and Hemostasis
|September 10, 2009
PubMed

Insights

Systolic heart failure patients may have a higher risk of blood clots. This review explores the prothrombotic state in heart failure and the potential benefits of anticoagulant therapy.

Area of Science:

  • Cardiology
  • Hematology

Background:

  • Systolic heart failure is a prevalent condition with increasing incidence.
  • Established treatments like beta-blockers and ACE inhibitors improve survival.
  • A prothrombotic state in heart failure suggests potential benefits from antithrombotic therapy.

Purpose of the Study:

  • To review the prothrombotic state in systolic heart failure.
  • To discuss the risk of thromboembolic events in these patients.
  • To explore the potential role of anticoagulant treatment.

Main Methods:

  • Literature review of studies on heart failure and thrombosis.
  • Analysis of pathophysiological mechanisms contributing to a prothrombotic state.
  • Evaluation of existing evidence on antithrombotic and anticoagulant treatments.

Main Results:

  • Observations suggest a prothrombotic state in patients with heart failure.
  • The risk of thromboembolic events in this population requires further elucidation.
  • The efficacy of antithrombotic treatment remains to be definitively established.

Conclusions:

  • Heart failure is associated with a prothrombotic state.
  • Further research is needed to clarify the role and efficacy of anticoagulant therapy in managing heart failure.
  • Understanding these mechanisms may lead to improved treatment strategies.

More Related Videos

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...